Clinical Trials Logo

Berylliosis clinical trials

View clinical trials related to Berylliosis.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06113991 Recruiting - Clinical trials for Pulmonary Sarcoidosis

Study Comparing Chronic Beryllium Disease to Pulmonary Sarcoidosis

BERYSARC
Start date: June 14, 2023
Phase:
Study type: Observational

Inhalation of beryllium can induce specific sensitization and diffuse pulmonary granulomatosis called chronic beryllium disease (CBD). The clinical, radiographic, and anatomopathological features of CBD are very similar to those of sarcoidosis, another granulomatosis, making its diagnosis difficult. In addition, the progression of CBD is poorly understood. The investigators hypothesis is that there are specific clinical, biological, anatomopathological, and radiological presentation specificities of CBD, as well as a worse prognosis compared to pulmonary sarcoidosis.